Sources | Names Used |
---|---|
CTRPv2 | BRD-K55116708 |
PharmacoGx | BRD-K55116708 |
Database | Identifier |
---|---|
Smiles: | C[C@@H](CO)N1C[C@@H](C)[C@@H](CN(C)Cc2ccc(cc2)C(=O)Nc3ccccc3N)Oc4c(NC(=O)Nc5ccccc5)cccc4C1=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FITM2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | HLA-DMA | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | CT45A10 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | RGPD3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | SPSB3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | TBX5 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | NICN1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | EMILIN2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | NUP133 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | C17orf89 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |